GRx+Biosims Conference

Wednesday April 4, 2018

AAM listened to our members and conference attendees and has created the ultimate event for the industry. We combined all our conferences — with the exception of the annual meeting — into the single best opportunity to hear directly from government officials, learn best practices and connect with peers in the generics and biosimilars industry.


GRx+Biosims is the name of the combined event that replaces FallTech, Leading on Biosimilars and CMC Workshop. The program will be comprehensive and the speakers are the top in their field. Whatever your interests, you will find what you need at GRx+Biosims. With science, policy and the market in constant flux, it is critical to come together as an industry to “engineer the future of generic and biosimilar medicines.”

View our meeting registration fees.

Be part of the GRx+Biosims 2018 Exposition.

Inquire about our sponsorship opportunities.

Follow the event on Twitter: #GRxBiosms

Hotel Information

Hilton Baltimore
401 W Pratt St.
Baltimore, MD 21201

Reservations must be made directly with the Hilton Baltimore by calling 1-800-445-8667 or online by clicking here. Please refer to the SRIP code “ATC” or “GRx+Biosims” to obtain the preferred rate. Only a limited number of preferred rate rooms are available. The preferred rate cut off date is August 8, 2018. After this date or after the preferred rate rooms are sold out, rooms are subject to hotel rates and availability.

GRx+Biosims Sponsors

GRx+Biosims Sponsors 2018

About the Biosimilars Council

The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is a leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public and health expert education, strategic partnerships, government affairs, legal affairs and regulatory policy. More information is available on our about page.

About AAM

AAM is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person’s life and the world around them. Generic and biosimilar medicines improve people’s lives, improving society and the economy in turn. AAM represents the manufacturers and distributors of finished generic pharmaceuticals and biosimilars, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals are 90 percent of prescriptions dispensed in the U.S. but only 23 percent of total drug spending. Additional information is available at

Stay Informed

Subscribe for Updates

Receive our monthly Biosimilars Bulletin and other important updates on biosimilars in the U.S.


Get Involved

The Council is involved in a number of events that focus on advancing biosimilars in the United States. Click on one below to learn more:



October 21–23, 2024 | Rockville, MD

GRx+Biosims™ 2024 is the leading regulatory science and policy event for the U.S. generics and biosimilars industry. Access the most recent information straight from experts at the Food and Drug Administration, grasp the latest policies shaping the industry, and acquire valuable insights to propel your professional development.